IFNγ causes mitochondrial dysfunction and oxidative stress in myositis
Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator ( Icos ), which have previously been shown to d...
Saved in:
| Published in: | Nature communications Vol. 15; no. 1; pp. 5403 - 18 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
Nature Publishing Group UK
26.06.2024
Nature Publishing Group Nature Portfolio |
| Subjects: | |
| ISSN: | 2041-1723, 2041-1723 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (
Icos
), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis.
Idiopathic inflammatory myopathies are severe autoimmune diseases with poorly understood pathogenesis. In this study, the authors use Icos-deficient NOD mice as a model for myositis, as well as clinical samples, to demonstrate mitochondrial abnormalities and metabolic dysfunction, which can be reversed by treatment with the ROS scavenger, N-acetylcysteine (NAC). |
|---|---|
| AbstractList | Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (Icos), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis.Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (Icos), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis. Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator ( Icos ), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis. Idiopathic inflammatory myopathies are severe autoimmune diseases with poorly understood pathogenesis. In this study, the authors use Icos-deficient NOD mice as a model for myositis, as well as clinical samples, to demonstrate mitochondrial abnormalities and metabolic dysfunction, which can be reversed by treatment with the ROS scavenger, N-acetylcysteine (NAC). Abstract Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (Icos), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis. Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (Icos), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis. Idiopathic inflammatory myopathies are severe autoimmune diseases with poorly understood pathogenesis. In this study, the authors use Icos-deficient NOD mice as a model for myositis, as well as clinical samples, to demonstrate mitochondrial abnormalities and metabolic dysfunction, which can be reversed by treatment with the ROS scavenger, N-acetylcysteine (NAC). Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator ( Icos ), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis. Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (Icos), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis. Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (Icos), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis. Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient in the inducible T cell co-stimulator (Icos), which have previously been shown to develop spontaneous IFNγ-driven myositis mimicking human disease. Using muscle proteomic and spatial transcriptomic analyses we reveal profound myofiber metabolic dysregulation in these mice. In addition, we report muscle mitochondrial abnormalities and oxidative stress in diseased mice. Supporting a pathogenic role for oxidative stress, treatment with a reactive oxygen species (ROS) buffer compound alleviated myositis, preserved muscle mitochondrial ultrastructure and respiration, and reduced inflammation. Mitochondrial anomalies and oxidative stress were diminished following anti-IFNγ treatment. Further transcriptomic analysis in IIMs patients and human myoblast in vitro studies supported the link between IFNγ and mitochondrial dysfunction observed in mice. These results suggest that mitochondrial dysfunction, ROS and inflammation are interconnected in a self-maintenance loop, opening perspectives for mitochondria therapy and/or ROS targeting drugs in myositis.Idiopathic inflammatory myopathies are severe autoimmune diseases with poorly understood pathogenesis. In this study, the authors use Icos-deficient NOD mice as a model for myositis, as well as clinical samples, to demonstrate mitochondrial abnormalities and metabolic dysfunction, which can be reversed by treatment with the ROS scavenger, N-acetylcysteine (NAC). |
| ArticleNumber | 5403 |
| Author | Meyer, Alain Abad, Catalina Boitard, Christian Giannini, Margherita Zoubairi, Rachid Remy-Jouet, Isabelle Drouot, Laurent Geny, Bernard Genty, Damien Jean, Laetitia Bourdenet, Gwladys Pinal-Fernandez, Iago Guillou, Clement Cosette, Pascal Debrut, Lea Boyer, Olivier Bernard, Sophie Mammen, Andrew |
| Author_xml | – sequence: 1 givenname: Catalina orcidid: 0000-0001-9144-9310 surname: Abad fullname: Abad, Catalina organization: Univ Rouen Normandie, Inserm, UMR1234, FOCIS Center of Excellence PAn’THER – sequence: 2 givenname: Iago orcidid: 0000-0001-6338-9218 surname: Pinal-Fernandez fullname: Pinal-Fernandez, Iago organization: Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Neurology, Johns Hopkins University School of Medicine – sequence: 3 givenname: Clement surname: Guillou fullname: Guillou, Clement organization: Univ Rouen Normandie, Inserm US 51, CNRS UAR 2026, HeRacLeS PISSARO – sequence: 4 givenname: Gwladys orcidid: 0000-0002-0076-2895 surname: Bourdenet fullname: Bourdenet, Gwladys organization: Univ Rouen Normandie, Inserm, UMR1234, FOCIS Center of Excellence PAn’THER – sequence: 5 givenname: Laurent surname: Drouot fullname: Drouot, Laurent organization: Univ Rouen Normandie, Inserm, UMR1234, FOCIS Center of Excellence PAn’THER – sequence: 6 givenname: Pascal surname: Cosette fullname: Cosette, Pascal organization: Univ Rouen Normandie, Inserm US 51, CNRS UAR 2026, HeRacLeS PISSARO, Univ Rouen Normandie, INSA Rouen Normandie, CNRS, Normandie Univ, PBS UMR 6270 – sequence: 7 givenname: Margherita surname: Giannini fullname: Giannini, Margherita organization: Translational Medicine Federation of Strasbourg, Team 3072, Faculty of Medicine, University of Strasbourg, Unité exploration fonctionnelle musculaire-service de physiologie, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares de l’Est et du Sud-Ouest -Service de rhumatologie, Hôpitaux Universitaires de Strasbourg – sequence: 8 givenname: Lea orcidid: 0000-0003-1534-8088 surname: Debrut fullname: Debrut, Lea organization: Translational Medicine Federation of Strasbourg, Team 3072, Faculty of Medicine, University of Strasbourg – sequence: 9 givenname: Laetitia surname: Jean fullname: Jean, Laetitia organization: Univ Rouen Normandie, Inserm, UMR1234, FOCIS Center of Excellence PAn’THER – sequence: 10 givenname: Sophie orcidid: 0009-0006-1411-9231 surname: Bernard fullname: Bernard, Sophie organization: Univ Rouen Normandie, Inserm US51, CNRS UAR2026, HeRacLeS PRIMACEN – sequence: 11 givenname: Damien surname: Genty fullname: Genty, Damien organization: CHU Rouen, Department of Pathology – sequence: 12 givenname: Rachid surname: Zoubairi fullname: Zoubairi, Rachid organization: Univ Rouen Normandie, Inserm, UMR1234, FOCIS Center of Excellence PAn’THER – sequence: 13 givenname: Isabelle surname: Remy-Jouet fullname: Remy-Jouet, Isabelle organization: Univ Rouen Normandie, Inserm, UMR1096, BOSS facility – sequence: 14 givenname: Bernard surname: Geny fullname: Geny, Bernard organization: Translational Medicine Federation of Strasbourg, Team 3072, Faculty of Medicine, University of Strasbourg, Unité exploration fonctionnelle musculaire-service de physiologie, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares de l’Est et du Sud-Ouest -Service de rhumatologie, Hôpitaux Universitaires de Strasbourg – sequence: 15 givenname: Christian surname: Boitard fullname: Boitard, Christian organization: Cochin Institute, Paris Descartes University, Sorbonne Paris Cité – sequence: 16 givenname: Andrew orcidid: 0000-0003-3732-3252 surname: Mammen fullname: Mammen, Andrew organization: Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Neurology, Johns Hopkins University School of Medicine, Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine – sequence: 17 givenname: Alain surname: Meyer fullname: Meyer, Alain organization: Translational Medicine Federation of Strasbourg, Team 3072, Faculty of Medicine, University of Strasbourg, Unité exploration fonctionnelle musculaire-service de physiologie, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares de l’Est et du Sud-Ouest -Service de rhumatologie, Hôpitaux Universitaires de Strasbourg – sequence: 18 givenname: Olivier orcidid: 0000-0002-7591-307X surname: Boyer fullname: Boyer, Olivier email: Olivier.boyer@chu-rouen.fr organization: Univ Rouen Normandie, Inserm, UMR1234, FOCIS Center of Excellence PAn’THER, CHU Rouen, Department of Immunology and Biotherapy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38926363$$D View this record in MEDLINE/PubMed https://hal.science/hal-04907493$$DView record in HAL |
| BookMark | eNp9ks1uEzEUhUeoiJbSF2CBRmIDiwH_z3iFqoq2kSLYwNpy7OvE0cQu9kzUPBfvwTPhZEppu6g3tq6_c-6VfV5XRyEGqKq3GH3CiHafM8NMtA0irGGSCdTgF9UJQQw3uCX06MH5uDrLeY3KohJ3jL2qjmkniaCCnlRXs8tvf37XRo8Zcr3xQzSrGGzyuq_tLrsxmMHHUOtg63jrrR78Fuo8JMi59qHe7GL2g89vqpdO9xnO7vbT6ufl1x8X1838-9Xs4nzeGN7yoWFsQRnnZmGo0dy2gJGVwChgbkXrtKaWECGcBnCIctI5TNsOLYTjmDin6Wk1m3xt1Gt1k_xGp52K2qtDIaal0mnwpgfFHSwoWIkcNUxqJh1Y0UkrhKS2zFC8vkxeN-NiA9ZAGJLuH5k-vgl-pZZxqzAmqOOSFIePk8Pqie76fK72NcQkapmkW1zYD3fdUvw1Qh7UxmcDfa8DxDErilrSIYJZV9D3T9B1HFMo73qgaMtbsafePRz_vv-_zy0AmQCTYs4J3D2CkdqHSE0hUiVE6hAitR-zeyIyftD7DJQn8P3zUjpJc-kTlpD-j_2M6i9_4Nt0 |
| CitedBy_id | crossref_primary_10_3390_ijms252111513 crossref_primary_10_1002_advs_202503095 crossref_primary_10_1016_j_ard_2025_07_015 crossref_primary_10_1093_rheumatology_keaf225 crossref_primary_10_1093_brain_awaf153 crossref_primary_10_3390_ijms26178369 crossref_primary_10_1016_j_autrev_2025_103817 crossref_primary_10_1186_s41232_025_00369_2 crossref_primary_10_1007_s00415_025_13192_z crossref_primary_10_1093_stcltm_szaf038 crossref_primary_10_1111_nan_70040 crossref_primary_10_3390_ijms26073302 crossref_primary_10_1016_j_it_2025_07_014 crossref_primary_10_3389_fimmu_2025_1578202 crossref_primary_10_1097_WCO_0000000000001393 crossref_primary_10_1111_cen3_12827 crossref_primary_10_3389_fimmu_2025_1567833 crossref_primary_10_3390_cells14120939 crossref_primary_10_2215_CJN_0000000745 crossref_primary_10_1186_s12969_025_01102_6 crossref_primary_10_1016_j_ard_2025_08_011 crossref_primary_10_1097_BOR_0000000000001112 crossref_primary_10_1016_j_phrs_2024_107505 crossref_primary_10_1097_BOR_0000000000001077 |
| Cites_doi | 10.1515/hsz-2013-0241 10.1016/j.redox.2014.05.004 10.1016/j.bbadis.2016.11.010 10.3389/fimmu.2018.00536 10.1016/j.freeradbiomed.2018.05.086 10.1080/10715760802623896 10.1016/j.cell.2010.07.036 10.1084/jem.20060845 10.1038/ni.3704 10.1002/path.4346 10.1038/s44318-024-00044-1 10.1007/s00204-013-1034-4 10.1113/expphysiol.2005.029835 10.1007/s00401-017-1731-9 10.3109/08820139.2012.751396 10.1038/nrrheum.2018.42 10.1126/sciimmunol.adi5377 10.1002/art.41964 10.1152/ajpendo.90323.2008 10.1002/ana.20464 10.3390/ijms222111673 10.1016/j.mito.2017.08.004 10.1097/BOR.0b013e32833f108a 10.1111/nan.12457 10.1038/s41584-022-00834-z 10.1056/NEJMoa2117912 10.1097/BOR.0000000000000748 10.1016/j.cell.2005.08.012 10.1093/braincomms/fcaa181 10.1212/WNL.0000000000008128 10.3390/ijms18061126 10.1515/BC.1999.178 10.1136/rmdopen-2022-002818 10.3389/fimmu.2023.1107670 10.18632/aging.102605 10.1016/S0014-5793(00)01464-2 10.3389/fcell.2022.796066 10.1002/eji.201040416 10.1038/s41572-021-00321-x 10.1093/nar/gkab1038 10.1186/1423-0127-21-23 10.1002/art.34625 10.1038/nmeth.2019 10.1056/NEJM199312303292704 10.1016/j.intimp.2022.108719 10.1016/j.autrev.2017.03.001 10.1016/j.nmd.2012.04.003 10.3389/fimmu.2017.00287 10.1038/s41418-019-0345-2 10.1007/s004010050462 10.1016/j.autrev.2008.04.013 10.3390/ijms222413384 10.1038/s41598-023-28838-z 10.1111/nan.12889 10.1016/j.expneurol.2015.11.010 10.1016/j.berh.2022.101762 10.1002/art.27465 10.1007/s12016-016-8527-x 10.1016/j.autrev.2008.04.019 10.1002/art.21130 10.1038/s41556-018-0124-1 10.1016/j.cmet.2010.09.016 10.1002/art.21103 10.1136/annrheumdis-2019-216599 10.1016/j.trsl.2018.07.014 10.1136/ard.54.6.491 10.1016/j.clim.2019.05.004 10.1172/jci.insight.141138 10.1016/j.molmed.2020.06.006 10.1038/srep15434 10.3390/antiox10030415 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. licence_http://creativecommons.org/publicdomain/zero |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: licence_http://creativecommons.org/publicdomain/zero |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 1XC VOOES 5PM DOA |
| DOI | 10.1038/s41467-024-49460-1 |
| DatabaseName | Open Access资源_Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection ProQuest Central Essentials ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database ProQuest Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest - Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) Open Access资源_DOAJ |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2041-1723 |
| EndPage | 18 |
| ExternalDocumentID | oai_doaj_org_article_5feb3ed90f3c49a49fed689d6693d55c PMC11208592 oai:HAL:hal-04907493v1 38926363 10_1038_s41467_024_49460_1 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: AFM-Téléthon (French Muscular Dystrophy Association) grantid: CLT/SS/19458 funderid: https://doi.org/10.13039/501100004923 – fundername: AFM-Téléthon (French Muscular Dystrophy Association) grantid: CLT/SS/19458 |
| GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LGEZI LK8 LOTEE M1P M48 M7P M~E NADUK NAO NXXTH O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX AFFHD CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI PRINS RC3 SOI 7X8 PUEGO 1XC 4.4 BAPOH CAG COF EJD VOOES 5PM |
| ID | FETCH-LOGICAL-c575t-44b3455cbc3ca5d7e10d9e43e15d67faa3d2266faeef03528f13780b6f512ffa3 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 26 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001256234400028&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2041-1723 |
| IngestDate | Fri Oct 03 12:42:17 EDT 2025 Tue Nov 04 02:05:33 EST 2025 Tue Dec 02 06:20:58 EST 2025 Sun Aug 24 03:54:56 EDT 2025 Tue Oct 07 07:24:03 EDT 2025 Wed Feb 19 02:06:39 EST 2025 Tue Nov 18 22:43:11 EST 2025 Sat Nov 29 03:30:07 EST 2025 Fri Feb 21 02:40:01 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2024. The Author(s). licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c575t-44b3455cbc3ca5d7e10d9e43e15d67faa3d2266faeef03528f13780b6f512ffa3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 PMCID: PMC11208592 |
| ORCID | 0000-0003-1534-8088 0000-0003-3732-3252 0009-0006-1411-9231 0000-0001-9144-9310 0000-0002-0076-2895 0000-0001-6338-9218 0000-0002-7591-307X 0000-0002-5824-6359 0000-0003-2879-9304 0000-0002-7588-0167 0000-0003-3985-9405 |
| OpenAccessLink | https://www.proquest.com/docview/3072375768?pq-origsite=%requestingapplication% |
| PMID | 38926363 |
| PQID | 3072375768 |
| PQPubID | 546298 |
| PageCount | 18 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_5feb3ed90f3c49a49fed689d6693d55c pubmedcentral_primary_oai_pubmedcentral_nih_gov_11208592 hal_primary_oai_HAL_hal_04907493v1 proquest_miscellaneous_3072802148 proquest_journals_3072375768 pubmed_primary_38926363 crossref_primary_10_1038_s41467_024_49460_1 crossref_citationtrail_10_1038_s41467_024_49460_1 springer_journals_10_1038_s41467_024_49460_1 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-06-26 |
| PublicationDateYYYYMMDD | 2024-06-26 |
| PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-26 day: 26 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Nature communications |
| PublicationTitleAbbrev | Nat Commun |
| PublicationTitleAlternate | Nat Commun |
| PublicationYear | 2024 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Chariot (CR12) 1996; 91 Bourdenet (CR18) 2023; 49 Jing (CR41) 2023; 14 Sidarala (CR44) 2020; 5 Tang (CR22) 2020; 27 Casal-Dominguez (CR70) 2023; 13 Spinelli, Haigis (CR48) 2018; 20 Ye (CR30) 2019; 205 Duteil (CR68) 2010; 12 Meyer (CR15) 2017; 134 Shah, Mahajan, Sah, Nath, Paudyal (CR34) 2014; 21 Campos, Arenas, Cabello, Gomez-Reino (CR14) 1995; 54 Klos, Dabravolski (CR42) 2021; 22 Becker, Duvvuri, Fortin, Lood, Boilard (CR43) 2022; 18 Bourdenet (CR66) 2018; 44 Lundberg (CR1) 2021; 7 Pinal-Fernandez (CR4) 2019; 93 Ohl, Tenbrock, Kipp (CR25) 2016; 277 Greenberg (CR3) 2005; 57 Dalakas (CR8) 1993; 329 Nakahira (CR35) 2006; 203 Fernandez (CR37) 1999; 380 Vignaud, Cebrian, Martelly, Caruelle, Ferry (CR67) 2005; 90 Schindelin (CR69) 2012; 9 Bhatti, Bhatti, Reddy (CR52) 2017; 1863 Mills, Kelly, O’Neill (CR54) 2017; 18 Zhang (CR59) 2023; 9 Lugrin, Rosenblatt-Velin, Parapanov, Liaudet (CR38) 2014; 395 Alhatou, Sladky, Bagasra, Glass (CR13) 2004; 35 Vringer (CR62) 2024; 43 Perez-Riverol (CR73) 2022; 50 Javadov, Chapa-Dubocq, Makarov (CR53) 2018; 38 Varadhachary, Weihl, Pestronk (CR40) 2010; 22 Smallwood (CR24) 2018; 125 Briet (CR17) 2017; 8 Griffiths (CR29) 2008; 7 Sinha, Das, Pal, Sil (CR23) 2013; 87 Chowdhury, Witte, Aich (CR61) 2022; 10 Ryan, Nissim, Winyard (CR28) 2014; 2 Shelly (CR11) 2020; 2 Seth, Sun, Ea, Chen (CR55) 2005; 122 Aggarwal (CR7) 2022; 387 Oka, Kamata, Kamata, Yagisawa, Hirata (CR36) 2000; 472 Kowalczyk (CR50) 2021; 22 Tournadre, Lenief, Miossec (CR60) 2010; 62 Coley (CR64) 2012; 64 Prevot (CR65) 2010; 40 CR51 Loredo Martinez (CR9) 2020; 32 Fransen, Lismont, Walton (CR63) 2017; 18 Morgan, Sturgess, Davies (CR32) 2009; 43 Meyer (CR49) 2018; 9 Ceribelli, De Santis, Isailovic, Gershwin, Selmi (CR2) 2017; 52 Morgan, Sturgess, Davies (CR31) 2005; 52 Casal-Dominguez (CR71) 2022; 74 Seifert (CR39) 2010; 142 Pinal-Fernandez (CR72) 2020; 79 Bourdenet (CR19) 2023; 49 Oddis, Aggarwal (CR5) 2018; 14 Kurien, Scofield (CR27) 2008; 7 Maiti (CR46) 2015; 5 Connolly, Plomp, Paik, Allenbach (CR6) 2022; 36 Banoth, Cassel (CR57) 2018; 202 Murphy (CR21) 2012; 22 Chen, Cao, Xiao, Li, Xue (CR20) 2020; 12 Suarez-Calvet (CR58) 2014; 233 Lu (CR45) 2008; 295 Nagaraju (CR10) 2005; 52 Bourgonje (CR26) 2020; 26 Al-Shobaili, Al Robaee, Alzolibani, Rasheed (CR33) 2013; 42 Qiu (CR56) 2022; 108 Afzali, Ruck, Wiendl, Meuth (CR16) 2017; 16 Langston (CR47) 2023; 8 Y Ye (49460_CR30) 2019; 205 AS Varadhachary (49460_CR40) 2010; 22 SA Greenberg (49460_CR3) 2005; 57 JB Spinelli (49460_CR48) 2018; 20 M Fransen (49460_CR63) 2017; 18 L Zhang (49460_CR59) 2023; 9 B Banoth (49460_CR57) 2018; 202 PE Morgan (49460_CR31) 2005; 52 S Shelly (49460_CR11) 2020; 2 PC Fernandez (49460_CR37) 1999; 380 Y Perez-Riverol (49460_CR73) 2022; 50 A Meyer (49460_CR15) 2017; 134 A Tournadre (49460_CR60) 2010; 62 J Schindelin (49460_CR69) 2012; 9 M Casal-Dominguez (49460_CR71) 2022; 74 K Nakahira (49460_CR35) 2006; 203 PE Morgan (49460_CR32) 2009; 43 AK Maiti (49460_CR46) 2015; 5 B Lu (49460_CR45) 2008; 295 IE Lundberg (49460_CR1) 2021; 7 MC Dalakas (49460_CR8) 1993; 329 K Nagaraju (49460_CR10) 2005; 52 D Duteil (49460_CR68) 2010; 12 S Oka (49460_CR36) 2000; 472 Y Qiu (49460_CR56) 2022; 108 A Vignaud (49460_CR67) 2005; 90 V Sidarala (49460_CR44) 2020; 5 J Tang (49460_CR22) 2020; 27 49460_CR51 MJ Smallwood (49460_CR24) 2018; 125 RB Seth (49460_CR55) 2005; 122 W Jing (49460_CR41) 2023; 14 K Ohl (49460_CR25) 2016; 277 P Klos (49460_CR42) 2021; 22 JS Bhatti (49460_CR52) 2017; 1863 A Chowdhury (49460_CR61) 2022; 10 G Bourdenet (49460_CR66) 2018; 44 BJ Ryan (49460_CR28) 2014; 2 E Vringer (49460_CR62) 2024; 43 A Meyer (49460_CR49) 2018; 9 J Lugrin (49460_CR38) 2014; 395 G Bourdenet (49460_CR18) 2023; 49 D Shah (49460_CR34) 2014; 21 Y Campos (49460_CR14) 1995; 54 X Suarez-Calvet (49460_CR58) 2014; 233 N Prevot (49460_CR65) 2010; 40 K Sinha (49460_CR23) 2013; 87 BT Kurien (49460_CR27) 2008; 7 JL Murphy (49460_CR21) 2012; 22 W Coley (49460_CR64) 2012; 64 I Pinal-Fernandez (49460_CR72) 2020; 79 YLC Becker (49460_CR43) 2022; 18 M Loredo Martinez (49460_CR9) 2020; 32 I Pinal-Fernandez (49460_CR4) 2019; 93 R Aggarwal (49460_CR7) 2022; 387 MI Alhatou (49460_CR13) 2004; 35 A Ceribelli (49460_CR2) 2017; 52 EL Mills (49460_CR54) 2017; 18 G Bourdenet (49460_CR19) 2023; 49 S Javadov (49460_CR53) 2018; 38 X Chen (49460_CR20) 2020; 12 U Seifert (49460_CR39) 2010; 142 AR Bourgonje (49460_CR26) 2020; 26 M Casal-Dominguez (49460_CR70) 2023; 13 P Chariot (49460_CR12) 1996; 91 HR Griffiths (49460_CR29) 2008; 7 C Briet (49460_CR17) 2017; 8 HA Al-Shobaili (49460_CR33) 2013; 42 CM Connolly (49460_CR6) 2022; 36 P Kowalczyk (49460_CR50) 2021; 22 AM Afzali (49460_CR16) 2017; 16 PK Langston (49460_CR47) 2023; 8 CV Oddis (49460_CR5) 2018; 14 |
| References_xml | – volume: 395 start-page: 203 year: 2014 end-page: 230 ident: CR38 article-title: The role of oxidative stress during inflammatory processes publication-title: Biol. Chem. doi: 10.1515/hsz-2013-0241 – volume: 2 start-page: 715 year: 2014 end-page: 724 ident: CR28 article-title: Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases publication-title: Redox Biol. doi: 10.1016/j.redox.2014.05.004 – volume: 1863 start-page: 1066 year: 2017 end-page: 1077 ident: CR52 article-title: Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria based therapeutic strategies publication-title: Biochim. Biophys. Acta Mol. Basis Dis. doi: 10.1016/j.bbadis.2016.11.010 – volume: 9 start-page: 536 year: 2018 ident: CR49 article-title: Mitochondria: an organelle of bacterial origin controlling inflammation publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.00536 – volume: 125 start-page: 3 year: 2018 end-page: 14 ident: CR24 article-title: Oxidative stress in autoimmune rheumatic diseases publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2018.05.086 – ident: CR51 – volume: 43 start-page: 117 year: 2009 end-page: 127 ident: CR32 article-title: Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients publication-title: Free Radic. Res. doi: 10.1080/10715760802623896 – volume: 142 start-page: 613 year: 2010 end-page: 624 ident: CR39 article-title: Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress publication-title: Cell doi: 10.1016/j.cell.2010.07.036 – volume: 203 start-page: 2377 year: 2006 end-page: 2389 ident: CR35 article-title: Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts publication-title: J. Exp. Med. doi: 10.1084/jem.20060845 – volume: 18 start-page: 488 year: 2017 end-page: 498 ident: CR54 article-title: Mitochondria are the powerhouses of immunity publication-title: Nat. Immunol. doi: 10.1038/ni.3704 – volume: 233 start-page: 258 year: 2014 end-page: 268 ident: CR58 article-title: Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis publication-title: J. Pathol. doi: 10.1002/path.4346 – volume: 43 start-page: 904 year: 2024 end-page: 930 ident: CR62 article-title: Mitochondrial outer membrane integrity regulates a ubiquitin-dependent and NF-kappaB-mediated inflammatory response publication-title: EMBO J. doi: 10.1038/s44318-024-00044-1 – volume: 87 start-page: 1157 year: 2013 end-page: 1180 ident: CR23 article-title: Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis publication-title: Arch. Toxicol. doi: 10.1007/s00204-013-1034-4 – volume: 90 start-page: 487 year: 2005 end-page: 495 ident: CR67 article-title: Effect of anti-inflammatory and antioxidant drugs on the long-term repair of severely injured mouse skeletal muscle publication-title: Exp. Physiol. doi: 10.1113/expphysiol.2005.029835 – volume: 134 start-page: 655 year: 2017 end-page: 666 ident: CR15 article-title: IFN-beta-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis publication-title: Acta Neuropathol. doi: 10.1007/s00401-017-1731-9 – volume: 42 start-page: 191 year: 2013 end-page: 203 ident: CR33 article-title: Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: correlation with disease activity index publication-title: Immunol. Invest. doi: 10.3109/08820139.2012.751396 – volume: 14 start-page: 279 year: 2018 end-page: 289 ident: CR5 article-title: Treatment in myositis publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2018.42 – volume: 8 year: 2023 ident: CR47 article-title: Regulatory T cells shield muscle mitochondria from interferon-gamma-mediated damage to promote the beneficial effects of exercise publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.adi5377 – volume: 74 start-page: 508 year: 2022 end-page: 517 ident: CR71 article-title: Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for idiopathic inflammatory myopathies in patients with myositis-specific autoantibodies publication-title: Arthritis Rheumatol. doi: 10.1002/art.41964 – volume: 295 start-page: E1502 year: 2008 end-page: E1509 ident: CR45 article-title: LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.90323.2008 – volume: 57 start-page: 664 year: 2005 end-page: 678 ident: CR3 article-title: Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis publication-title: Ann. Neurol. doi: 10.1002/ana.20464 – volume: 22 start-page: 11673 year: 2021 ident: CR42 article-title: The role of mitochondria dysfunction in inflammatory bowel diseases and colorectal cancer publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms222111673 – volume: 38 start-page: 58 year: 2018 end-page: 70 ident: CR53 article-title: Different approaches to modeling analysis of mitochondrial swelling publication-title: Mitochondrion doi: 10.1016/j.mito.2017.08.004 – volume: 22 start-page: 651 year: 2010 end-page: 657 ident: CR40 article-title: Mitochondrial pathology in immune and inflammatory myopathies publication-title: Curr. Opin. Rheumatol. doi: 10.1097/BOR.0b013e32833f108a – volume: 44 start-page: 537 year: 2018 end-page: 540 ident: CR66 article-title: Value of magnetic resonance imaging for evaluating muscle inflammation: insights from a new mouse model of myositis publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12457 – volume: 18 start-page: 621 year: 2022 end-page: 640 ident: CR43 article-title: The role of mitochondria in rheumatic diseases publication-title: Nat. Rev. Rheumatol. doi: 10.1038/s41584-022-00834-z – volume: 387 start-page: 1264 year: 2022 end-page: 1278 ident: CR7 article-title: Trial of intravenous immune globulin in dermatomyositis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2117912 – volume: 32 start-page: 515 year: 2020 end-page: 522 ident: CR9 article-title: Nonimmune mechanisms in idiopathic inflammatory myopathies publication-title: Curr. Opin. Rheumatol. doi: 10.1097/BOR.0000000000000748 – volume: 122 start-page: 669 year: 2005 end-page: 682 ident: CR55 article-title: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3 publication-title: Cell doi: 10.1016/j.cell.2005.08.012 – volume: 2 year: 2020 ident: CR11 article-title: Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy publication-title: Brain Commun. doi: 10.1093/braincomms/fcaa181 – volume: 93 start-page: e1193 year: 2019 end-page: e1204 ident: CR4 article-title: Identification of distinctive interferon gene signatures in different types of myositis publication-title: Neurology doi: 10.1212/WNL.0000000000008128 – volume: 18 start-page: 1126 year: 2017 ident: CR63 article-title: The peroxisome-mitochondria connection: how and why? publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18061126 – volume: 380 start-page: 1383 year: 1999 end-page: 1394 ident: CR37 article-title: The inhibition of NF-kappaB activation pathways and the induction of apoptosis by dithiocarbamates in T cells are blocked by the glutathione precursor N-acetyl-L-cysteine publication-title: Biol. Chem. doi: 10.1515/BC.1999.178 – volume: 9 start-page: e002818 year: 2023 ident: CR59 article-title: Immunoproteasome subunit beta5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I publication-title: RMD Open doi: 10.1136/rmdopen-2022-002818 – volume: 14 year: 2023 ident: CR41 article-title: Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs publication-title: Front. Immunol. doi: 10.3389/fimmu.2023.1107670 – volume: 12 start-page: 122 year: 2020 end-page: 137 ident: CR20 article-title: PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress publication-title: Aging doi: 10.18632/aging.102605 – volume: 472 start-page: 196 year: 2000 end-page: 202 ident: CR36 article-title: N-acetylcysteine suppresses TNF-induced NF-kappaB activation through inhibition of IkappaB kinases publication-title: FEBS Lett. doi: 10.1016/S0014-5793(00)01464-2 – volume: 10 start-page: 796066 year: 2022 ident: CR61 article-title: Role of mitochondrial nucleic acid sensing pathways in health and patho-physiology publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2022.796066 – volume: 40 start-page: 2267 year: 2010 end-page: 2276 ident: CR65 article-title: Abrogation of ICOS/ICOS ligand costimulation in NOD mice results in autoimmune deviation toward the neuromuscular system publication-title: Eur. J. Immunol. doi: 10.1002/eji.201040416 – volume: 7 start-page: 86 year: 2021 ident: CR1 article-title: Idiopathic inflammatory myopathies publication-title: Nat. Rev. Dis. Prim. doi: 10.1038/s41572-021-00321-x – volume: 50 start-page: D543 year: 2022 end-page: D552 ident: CR73 article-title: The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkab1038 – volume: 21 start-page: 23 year: 2014 ident: CR34 article-title: Oxidative stress and its biomarkers in systemic lupus erythematosus publication-title: J. Biomed. Sci. doi: 10.1186/1423-0127-21-23 – volume: 64 start-page: 3750 year: 2012 end-page: 3759 ident: CR64 article-title: The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy publication-title: Arthritis Rheum. doi: 10.1002/art.34625 – volume: 9 start-page: 676 year: 2012 end-page: 682 ident: CR69 article-title: Fiji: an open-source platform for biological-image analysis publication-title: Nat. Methods doi: 10.1038/nmeth.2019 – volume: 329 start-page: 1993 year: 1993 end-page: 2000 ident: CR8 article-title: A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199312303292704 – volume: 108 year: 2022 ident: CR56 article-title: Mitochondrial DNA in NLRP3 inflammasome activation publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2022.108719 – volume: 16 start-page: 478 year: 2017 end-page: 494 ident: CR16 article-title: Animal models in idiopathic inflammatory myopathies: how to overcome a translational roadblock? publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2017.03.001 – volume: 22 start-page: 690 year: 2012 end-page: 698 ident: CR21 article-title: Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy publication-title: Neuromuscul. Disord. doi: 10.1016/j.nmd.2012.04.003 – volume: 8 start-page: 287 year: 2017 ident: CR17 article-title: The spontaneous autoimmune neuromyopathy in ICOSL(-/-) NOD mice Is CD4(+) T-cell and interferon-gamma dependent publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.00287 – volume: 27 start-page: 146 year: 2020 end-page: 160 ident: CR22 article-title: Sam50-Mic19-Mic60 axis determines mitochondrial cristae architecture by mediating mitochondrial outer and inner membrane contact publication-title: Cell Death Differ. doi: 10.1038/s41418-019-0345-2 – volume: 91 start-page: 530 year: 1996 end-page: 536 ident: CR12 article-title: Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies publication-title: Acta Neuropathol. doi: 10.1007/s004010050462 – volume: 7 start-page: 544 year: 2008 end-page: 549 ident: CR29 article-title: Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2008.04.013 – volume: 22 start-page: 13384 year: 2021 ident: CR50 article-title: Mitochondrial oxidative stress-a causative factor and therapeutic target in many diseases publication-title: Int J. Mol. Sci. doi: 10.3390/ijms222413384 – volume: 13 year: 2023 ident: CR70 article-title: Coordinated local RNA overexpression of complement induced by interferon gamma in myositis publication-title: Sci. Rep. doi: 10.1038/s41598-023-28838-z – volume: 49 year: 2023 ident: CR19 article-title: Icos gene disruption in non-obese diabetic mice elicits myositis associated with anti-troponin T3 autoantibodies publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12889 – volume: 277 start-page: 58 year: 2016 end-page: 67 ident: CR25 article-title: Oxidative stress in multiple sclerosis: central and peripheral mode of action publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2015.11.010 – volume: 35 start-page: 615 year: 2004 end-page: 619 ident: CR13 article-title: Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology publication-title: J. Mol. Histol. – volume: 36 start-page: 101762 year: 2022 ident: CR6 article-title: Possible future avenues for myositis therapeutics: DM, IMNM and IBM publication-title: Best. Pr. Res Clin. Rheumatol. doi: 10.1016/j.berh.2022.101762 – volume: 62 start-page: 2144 year: 2010 end-page: 2151 ident: CR60 article-title: Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines publication-title: Arthritis Rheum. doi: 10.1002/art.27465 – volume: 52 start-page: 58 year: 2017 end-page: 70 ident: CR2 article-title: The immune response and the pathogenesis of idiopathic inflammatory myositis: a critical review publication-title: Clin. Rev. Allergy Immunol. doi: 10.1007/s12016-016-8527-x – volume: 7 start-page: 567 year: 2008 end-page: 573 ident: CR27 article-title: Autoimmunity and oxidatively modified autoantigens publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2008.04.019 – volume: 52 start-page: 2069 year: 2005 end-page: 2079 ident: CR31 article-title: Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus publication-title: Arthritis Rheum. doi: 10.1002/art.21130 – volume: 20 start-page: 745 year: 2018 end-page: 754 ident: CR48 article-title: The multifaceted contributions of mitochondria to cellular metabolism publication-title: Nat. Cell Biol. doi: 10.1038/s41556-018-0124-1 – volume: 12 start-page: 496 year: 2010 end-page: 508 ident: CR68 article-title: The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles publication-title: Cell Metab. doi: 10.1016/j.cmet.2010.09.016 – volume: 52 start-page: 1824 year: 2005 end-page: 1835 ident: CR10 article-title: Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction publication-title: Arthritis Rheum. doi: 10.1002/art.21103 – volume: 79 start-page: 1234 year: 2020 end-page: 1242 ident: CR72 article-title: Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2019-216599 – volume: 202 start-page: 52 year: 2018 end-page: 68 ident: CR57 article-title: Mitochondria in innate immune signaling publication-title: Transl. Res. doi: 10.1016/j.trsl.2018.07.014 – volume: 54 start-page: 491 year: 1995 end-page: 493 ident: CR14 article-title: Respiratory chain enzyme defects in patients with idiopathic inflammatory myopathy publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.54.6.491 – volume: 49 start-page: e12889 year: 2023 ident: CR18 article-title: Icos gene disruption in NOD mice elicits myositis associated with anti-troponin T3 autoantibodies publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12889 – volume: 205 start-page: 43 year: 2019 end-page: 48 ident: CR30 article-title: Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE publication-title: Clin. Immunol. doi: 10.1016/j.clim.2019.05.004 – volume: 5 start-page: e141138 year: 2020 ident: CR44 article-title: Mitophagy protects beta cells from inflammatory damage in diabetes publication-title: JCI Insight doi: 10.1172/jci.insight.141138 – volume: 26 start-page: 1034 year: 2020 end-page: 1046 ident: CR26 article-title: Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2020.06.006 – volume: 5 year: 2015 ident: CR46 article-title: IL-4 protects the mitochondria against TNFalpha and IFNgamma induced insult during clearance of infection with citrobacter rodentium and Escherichia coli publication-title: Sci. Rep. doi: 10.1038/srep15434 – volume: 329 start-page: 1993 year: 1993 ident: 49460_CR8 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199312303292704 – volume: 13 year: 2023 ident: 49460_CR70 publication-title: Sci. Rep. doi: 10.1038/s41598-023-28838-z – volume: 42 start-page: 191 year: 2013 ident: 49460_CR33 publication-title: Immunol. Invest. doi: 10.3109/08820139.2012.751396 – volume: 14 year: 2023 ident: 49460_CR41 publication-title: Front. Immunol. doi: 10.3389/fimmu.2023.1107670 – volume: 7 start-page: 544 year: 2008 ident: 49460_CR29 publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2008.04.013 – volume: 90 start-page: 487 year: 2005 ident: 49460_CR67 publication-title: Exp. Physiol. doi: 10.1113/expphysiol.2005.029835 – volume: 472 start-page: 196 year: 2000 ident: 49460_CR36 publication-title: FEBS Lett. doi: 10.1016/S0014-5793(00)01464-2 – volume: 5 start-page: e141138 year: 2020 ident: 49460_CR44 publication-title: JCI Insight doi: 10.1172/jci.insight.141138 – volume: 277 start-page: 58 year: 2016 ident: 49460_CR25 publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2015.11.010 – volume: 43 start-page: 904 year: 2024 ident: 49460_CR62 publication-title: EMBO J. doi: 10.1038/s44318-024-00044-1 – volume: 2 year: 2020 ident: 49460_CR11 publication-title: Brain Commun. doi: 10.1093/braincomms/fcaa181 – volume: 21 start-page: 23 year: 2014 ident: 49460_CR34 publication-title: J. Biomed. Sci. doi: 10.1186/1423-0127-21-23 – volume: 38 start-page: 58 year: 2018 ident: 49460_CR53 publication-title: Mitochondrion doi: 10.1016/j.mito.2017.08.004 – volume: 9 start-page: 536 year: 2018 ident: 49460_CR49 publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.00536 – volume: 93 start-page: e1193 year: 2019 ident: 49460_CR4 publication-title: Neurology doi: 10.1212/WNL.0000000000008128 – volume: 7 start-page: 567 year: 2008 ident: 49460_CR27 publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2008.04.019 – volume: 14 start-page: 279 year: 2018 ident: 49460_CR5 publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2018.42 – volume: 12 start-page: 122 year: 2020 ident: 49460_CR20 publication-title: Aging doi: 10.18632/aging.102605 – volume: 142 start-page: 613 year: 2010 ident: 49460_CR39 publication-title: Cell doi: 10.1016/j.cell.2010.07.036 – volume: 20 start-page: 745 year: 2018 ident: 49460_CR48 publication-title: Nat. Cell Biol. doi: 10.1038/s41556-018-0124-1 – volume: 395 start-page: 203 year: 2014 ident: 49460_CR38 publication-title: Biol. Chem. doi: 10.1515/hsz-2013-0241 – volume: 22 start-page: 11673 year: 2021 ident: 49460_CR42 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms222111673 – volume: 9 start-page: e002818 year: 2023 ident: 49460_CR59 publication-title: RMD Open doi: 10.1136/rmdopen-2022-002818 – volume: 35 start-page: 615 year: 2004 ident: 49460_CR13 publication-title: J. Mol. Histol. – volume: 22 start-page: 690 year: 2012 ident: 49460_CR21 publication-title: Neuromuscul. Disord. doi: 10.1016/j.nmd.2012.04.003 – volume: 2 start-page: 715 year: 2014 ident: 49460_CR28 publication-title: Redox Biol. doi: 10.1016/j.redox.2014.05.004 – volume: 22 start-page: 651 year: 2010 ident: 49460_CR40 publication-title: Curr. Opin. Rheumatol. doi: 10.1097/BOR.0b013e32833f108a – volume: 43 start-page: 117 year: 2009 ident: 49460_CR32 publication-title: Free Radic. Res. doi: 10.1080/10715760802623896 – volume: 40 start-page: 2267 year: 2010 ident: 49460_CR65 publication-title: Eur. J. Immunol. doi: 10.1002/eji.201040416 – volume: 74 start-page: 508 year: 2022 ident: 49460_CR71 publication-title: Arthritis Rheumatol. doi: 10.1002/art.41964 – volume: 64 start-page: 3750 year: 2012 ident: 49460_CR64 publication-title: Arthritis Rheum. doi: 10.1002/art.34625 – volume: 8 year: 2023 ident: 49460_CR47 publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.adi5377 – volume: 295 start-page: E1502 year: 2008 ident: 49460_CR45 publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.90323.2008 – volume: 18 start-page: 621 year: 2022 ident: 49460_CR43 publication-title: Nat. Rev. Rheumatol. doi: 10.1038/s41584-022-00834-z – volume: 16 start-page: 478 year: 2017 ident: 49460_CR16 publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2017.03.001 – volume: 380 start-page: 1383 year: 1999 ident: 49460_CR37 publication-title: Biol. Chem. doi: 10.1515/BC.1999.178 – volume: 5 year: 2015 ident: 49460_CR46 publication-title: Sci. Rep. doi: 10.1038/srep15434 – volume: 26 start-page: 1034 year: 2020 ident: 49460_CR26 publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2020.06.006 – ident: 49460_CR51 doi: 10.3390/antiox10030415 – volume: 62 start-page: 2144 year: 2010 ident: 49460_CR60 publication-title: Arthritis Rheum. doi: 10.1002/art.27465 – volume: 22 start-page: 13384 year: 2021 ident: 49460_CR50 publication-title: Int J. Mol. Sci. doi: 10.3390/ijms222413384 – volume: 49 year: 2023 ident: 49460_CR19 publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12889 – volume: 125 start-page: 3 year: 2018 ident: 49460_CR24 publication-title: Free Radic. Biol. Med. doi: 10.1016/j.freeradbiomed.2018.05.086 – volume: 44 start-page: 537 year: 2018 ident: 49460_CR66 publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12457 – volume: 52 start-page: 2069 year: 2005 ident: 49460_CR31 publication-title: Arthritis Rheum. doi: 10.1002/art.21130 – volume: 52 start-page: 58 year: 2017 ident: 49460_CR2 publication-title: Clin. Rev. Allergy Immunol. doi: 10.1007/s12016-016-8527-x – volume: 32 start-page: 515 year: 2020 ident: 49460_CR9 publication-title: Curr. Opin. Rheumatol. doi: 10.1097/BOR.0000000000000748 – volume: 8 start-page: 287 year: 2017 ident: 49460_CR17 publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.00287 – volume: 18 start-page: 488 year: 2017 ident: 49460_CR54 publication-title: Nat. Immunol. doi: 10.1038/ni.3704 – volume: 49 start-page: e12889 year: 2023 ident: 49460_CR18 publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12889 – volume: 203 start-page: 2377 year: 2006 ident: 49460_CR35 publication-title: J. Exp. Med. doi: 10.1084/jem.20060845 – volume: 18 start-page: 1126 year: 2017 ident: 49460_CR63 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18061126 – volume: 205 start-page: 43 year: 2019 ident: 49460_CR30 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2019.05.004 – volume: 233 start-page: 258 year: 2014 ident: 49460_CR58 publication-title: J. Pathol. doi: 10.1002/path.4346 – volume: 122 start-page: 669 year: 2005 ident: 49460_CR55 publication-title: Cell doi: 10.1016/j.cell.2005.08.012 – volume: 52 start-page: 1824 year: 2005 ident: 49460_CR10 publication-title: Arthritis Rheum. doi: 10.1002/art.21103 – volume: 202 start-page: 52 year: 2018 ident: 49460_CR57 publication-title: Transl. Res. doi: 10.1016/j.trsl.2018.07.014 – volume: 57 start-page: 664 year: 2005 ident: 49460_CR3 publication-title: Ann. Neurol. doi: 10.1002/ana.20464 – volume: 79 start-page: 1234 year: 2020 ident: 49460_CR72 publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2019-216599 – volume: 387 start-page: 1264 year: 2022 ident: 49460_CR7 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2117912 – volume: 91 start-page: 530 year: 1996 ident: 49460_CR12 publication-title: Acta Neuropathol. doi: 10.1007/s004010050462 – volume: 87 start-page: 1157 year: 2013 ident: 49460_CR23 publication-title: Arch. Toxicol. doi: 10.1007/s00204-013-1034-4 – volume: 27 start-page: 146 year: 2020 ident: 49460_CR22 publication-title: Cell Death Differ. doi: 10.1038/s41418-019-0345-2 – volume: 1863 start-page: 1066 year: 2017 ident: 49460_CR52 publication-title: Biochim. Biophys. Acta Mol. Basis Dis. doi: 10.1016/j.bbadis.2016.11.010 – volume: 50 start-page: D543 year: 2022 ident: 49460_CR73 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkab1038 – volume: 54 start-page: 491 year: 1995 ident: 49460_CR14 publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.54.6.491 – volume: 9 start-page: 676 year: 2012 ident: 49460_CR69 publication-title: Nat. Methods doi: 10.1038/nmeth.2019 – volume: 36 start-page: 101762 year: 2022 ident: 49460_CR6 publication-title: Best. Pr. Res Clin. Rheumatol. doi: 10.1016/j.berh.2022.101762 – volume: 10 start-page: 796066 year: 2022 ident: 49460_CR61 publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2022.796066 – volume: 108 year: 2022 ident: 49460_CR56 publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2022.108719 – volume: 12 start-page: 496 year: 2010 ident: 49460_CR68 publication-title: Cell Metab. doi: 10.1016/j.cmet.2010.09.016 – volume: 7 start-page: 86 year: 2021 ident: 49460_CR1 publication-title: Nat. Rev. Dis. Prim. doi: 10.1038/s41572-021-00321-x – volume: 134 start-page: 655 year: 2017 ident: 49460_CR15 publication-title: Acta Neuropathol. doi: 10.1007/s00401-017-1731-9 |
| SSID | ssj0000391844 |
| Score | 2.56776 |
| Snippet | Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role... Abstract Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine... |
| SourceID | doaj pubmedcentral hal proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 5403 |
| SubjectTerms | 13 13/51 14/1 14/105 14/28 14/63 38/77 49/88 631/250/249/1313 631/250/256/2515 631/250/38 64/60 82/79 Abnormalities Acetylcysteine Adaptive immunology Animals Autoimmune diseases Biochemistry, Molecular Biology Disease Models, Animal Drug delivery Female Genomics Health services Human health and pathology Humanities and Social Sciences Humans Immunology Innate immunity Interferon-gamma - metabolism Life Sciences Lymphocytes Lymphocytes T Metabolism Mice Mice, Inbred NOD Mice, Knockout Mitochondria Mitochondria - drug effects Mitochondria - metabolism Mitochondria, Muscle - metabolism Mitochondria, Muscle - pathology multidisciplinary Muscle, Skeletal - metabolism Muscle, Skeletal - pathology Muscles Myoblasts Myoblasts - metabolism Myositis Myositis - genetics Myositis - metabolism Myositis - pathology Oxidative Stress Pathogenesis Proteomics Reactive oxygen species Reactive Oxygen Species - metabolism Science Science (multidisciplinary) Spatial analysis Stimulators Transcriptomics Ultrastructure γ-Interferon |
| SummonAdditionalLinks | – databaseName: Open Access资源_DOAJ dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQBRIXxJvQggziBlaTjOPEx4JYilStOIDUm-X4oa5Es6jpVuzv6v_gNzHjZJeGCrhwtSeONZ6nZvyZsVde2iJ67QRGu0rIABJVKjoRcutLD20FMaHrH9XzeXN8rD9deeqLesIGeOCBcftVxHQveJ1HcFJbqWPwqtFeKQ2-qhxZX4x6riRTyQaDxtRFjrdkcmj2e5lsArokIbVUuSgmnigB9qN_OaF2yOux5vWWyd_qpskdze6yO2McyQ-G_d9jN0J3n90aXpZcP2AfPs7mPy65s6s-9PwU1RbNXOdJ2rhf9-TN6ES47Txffl_4BP_Nh4sjfNHx03Vq5uofsi-z95_fHYrxzQThMPA6F1K2IJEtrQNnK1-HIvc6SAhF5VUdrQWPAZeKNoRIUKhNLKBu8lZF9PwxWnjEdrplF54wXqtat8oVUUqHy3obJXhlq7JqI1UDM1Zs-GfcCChO71p8NamwDY0ZeG6Q5ybx3BQZe7395tsAp_FX6rd0LFtKgsJOAyggZhQQ8y8BydhLPNTJGocHR4bGqOpZSw0X-Ke9zZmbUYl7g-avhJoSsoy92E6j-lFNxXZhuRpoGsKdQ5rHg4hsf4WxYKlAQcaaifBM9jKd6RYnCeIbo2BCnisz9mYjZ7_29WeGPf0fDNtlt0tSk1yJUu2xnfOzVXjGbroLlLqz50nPfgI0LSu1 priority: 102 providerName: Directory of Open Access Journals |
| Title | IFNγ causes mitochondrial dysfunction and oxidative stress in myositis |
| URI | https://link.springer.com/article/10.1038/s41467-024-49460-1 https://www.ncbi.nlm.nih.gov/pubmed/38926363 https://www.proquest.com/docview/3072375768 https://www.proquest.com/docview/3072802148 https://hal.science/hal-04907493 https://pubmed.ncbi.nlm.nih.gov/PMC11208592 https://doaj.org/article/5feb3ed90f3c49a49fed689d6693d55c |
| Volume | 15 |
| WOSCitedRecordID | wos001256234400028&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: P5Z dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M7P dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: 7X7 dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central (New) customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: BENPR dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: PIMPY dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoCxIX3oVAWQXEDaImsePEJ9SiLq1UVhECaeFiOX7QlWhSNt2K_V38D34TM0421VLRC5ccYidxMq9Pnsk3hLwyTCXOCB0B2uURs5SBSTkd2ViZ1NAqo86z6x_nk0kxnYqy33Br-7LKlU_0jto0GvfId0EXU5ojOn579iPCrlGYXe1baGyQLWRJoL50rxz2WJD9vGCs_1cmpsVuy7xngMAUMcF4HCVr8cjT9kOUOcGiyKuI82rh5F_ZUx-Uxnf_93XukTs9HA33Ov25T27Y-gG51TWoXD4k74_Gk9-_Qq0WrW3DU7B-8Ja1QaUNzbLFoIiCDVVtwubnzHgW8bD7_ySc1eHp0teEtY_I5_HBp3eHUd96IdKA384jxirKskxXmmqVmdwmsRGWUZtkhudOKWoAt3GnrHXIqFq4hOZFXHEHAMI5RbfJZt3U9gkJc56LiuvEMabhtkY5Rg1XWZpVDpOKAUlWApC65yXH9hjfpc-P00J2QpMgNOmFJpOAvB6uOetYOa6dvY9yHWYio7Y_0cy_yd5AZeZsRa0RsaOaCcWEs4YXwnAuqIEvEZCXoBVr9zjcO5Z4DpOnORP0Ap60s5K27H1BKy9FHZAXwzBYMaZmVG2bRTenQPo6mPO407HhUQApU045DUixpn1ra1kfqWcnnikcwDQS2KUBebNS1Mt1_fuDPb3-NZ6R2ylaUMyjlO-QzfP5wj4nN_UF6NN8RDbyae6PxYhs7R9Myo8jv9Mx8sYJxzL7CiPl0Yfyyx_sNj_a |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAioX3o9AgYDgVKImsePEB4TKY9lVl1UPRerNOH60K9Fs2XQL-6e48D_4TYydZKulorceuDqOnTjfPJwZfwPwQlOZWM1VhN4ui6ghFEXKqsjEUqealBmxnl1_mI9Gxd4e31mBn91ZGJdW2elEr6j1RLl_5JuIxZTkzjt-c_QtclWjXHS1K6HRwGLbzL_jlq1-PXiP3_dlmvY-7L7rR21VgUiha3IcUVoSmmWqVETJTOcmiTU3lJgk0yy3UhKNLgmz0hjryEILm5C8iEtm0TZaKwmOewkuoxuRFj5VcGfxT8exrReUtmdzYlJs1tRrIjSEEeWUxVGyZP98mQC0agcuCfOsh3s2UfOvaK03gr0b_9vy3YTrrbsdbjXycQtWTHUbrjYFOOd34OOgN_r9K1RyVps6PETthtag0k4oQz2vndF3wA1lpcPJj7H2LOlhc74mHFfh4dznvNV34fOFvMU9WK0mlXkAYc5yXjKVWEoVDqulpUQzmaVZaV3QNICk--BCtbzrrvzHV-Hj_6QQDUgEgkR4kIgkgI3FPUcN68i5vd86HC16OsZw3zCZ7otWAYnMmpIYzWNLFOWScms0K7hmjBONKxHAc0Th0hj9raFwbS44nFNOTnCm9Q5dotV1tTiFVgDPFpdRS7nQk6zMZNb0KRw9H_a532B6MRW6zCkjjARQLKF96VmWr1TjA8-EjpsFR9CXBvCqE4zT5_r3gj08_zWewlp_99NQDAej7UdwLXXSG7MoZeuwejydmcdwRZ0gtqZPvPiH8OWiBeYP_JWXBQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8hAX3o9AAYPgBNEmseMkB4QKZemqq9UeQOrNOH60K7XZsukW9ndx40fwmxg7yVZLRW89cHUcO3G-eTgz_gbgpWYytrpQIXq7PGSGMhQpq0ITSZ1oWqbUenb9YTYa5bu7xXgNfnVnYVxaZacTvaLWU-X-kfcQiwnNnHfcs21axHir_-7oW-gqSLlIa1dOo4HIjll8x-1b_Xawhd_6VZL0P37-sB22FQZChW7KcchYSVmaqlJRJVOdmTjShWHUxKnmmZWSanRPuJXGWEccmtuYZnlUcot20lpJcdxLcDlzpOU-bXC8_L_jmNdzxtpzOhHNezXzWgmNYsgKxqMwXrGFvmQAWrh9l5B51ts9m7T5V-TWG8T-zf95KW_BjdYNJ5uN3NyGNVPdgatNYc7FXfg06I9-_yRKzmtTk0PUemglKu2ElehF7ZwBB2giK02mPybas6eT5twNmVTkcOFz4ep78OVC3uI-rFfTyjwEkvGsKLmKLWMKh9XSMqq5TJO0tC6YGkDcfXyhWj52VxbkQPi8AJqLBjACASM8YEQcwOvlPUcNG8m5vd87TC17OiZx3zCd7YlWMYnUmpIaXUSWKlZIVlijeV5ozguqcSUCeIGIXBlje3MoXJsLGmesoCc400aHNNHqwFqcwiyA58vLqL1cSEpWZjpv-uSOtg_7PGjwvZwKXemEU04DyFeQv_Isq1eqyb5nSMdNhCPuSwJ40wnJ6XP9e8Eenf8az-AayokYDkY7j-F64gQ54mHCN2D9eDY3T-CKOkFozZ56TUDg60XLyx_r1p_C |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IFN%CE%B3+causes+mitochondrial+dysfunction+and+oxidative+stress+in+myositis&rft.jtitle=Nature+communications&rft.au=Abad%2C+Catalina&rft.au=Pinal-Fernandez%2C+Iago&rft.au=Guillou%2C+Clement&rft.au=Bourdenet%2C+Gwladys&rft.date=2024-06-26&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2041-1723&rft.volume=15&rft_id=info:doi/10.1038%2Fs41467-024-49460-1&rft_id=info%3Apmid%2F38926363&rft.externalDocID=PMC11208592 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |